Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v13-FR Version v3-FR
Language French French
Date Updated 2018-06-12 2018-05-28
Drug Identification Number 02245274 02245274
Brand name AMARYL AMARYL
Common or Proper name AMARYL 4mg AMARYL
Company Name SANOFI-AVENTIS CANADA INC SANOFI-AVENTIS CANADA INC
Ingredients GLIMEPIRIDE GLIMEPIRIDE
Strength(s) 4MG 4MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 30's 30's
ATC code A10BB A10BB
ATC description BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date 2018-05-29 2018-05-28
Actual start date 2018-05-29 2018-05-28
Estimated end date 2018-06-01 Unknown
Actual end date 2018-06-07
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments Product discontinuation is anticipated June 1, 2018 Product discontinuation is anticipated
Health Canada comments